We have located links that may give you full text access.
Anti-biofilm activity against Gram-positive bacteria by biologically synthesized silver nanoparticles using Curcuma longa.
Pharmaceutical Nanotechnology 2018 June 30
OBJECTIVE: To assess the biofilm inhibition activity of biosynthesized silver nanoparticles (AgNPs) using Curcuma longa.
METHODS: Characterizations of these biogenic nanoparticles were done by UV-Vis spectroscopy, TEM, EDX and nanoparticles tracking analyzer. Antibiofilm activity of AgNPs against S. aureus and S. pneumoniae was carried out by 96 well plate method. Further the combined effect of AgNPs with the antibiotic was studied against S. aureus and S. pneumoniae.
RESULTS: UV-spectroscopic analysis showed a surface plasmon resonance peak at 415nm. Shape of AgNPs is spherical with average size of 20-40 nm while the elemental silver was confirmed by EDX analysis. These biosynthesized AgNPs have anti-biofilm activity against S. aureus and S. pneumoniae. Furthermore, the combined effect of AgNPs with antibiotic, showed enhanced anti-biofilm activity against both the strains under study.
CONCLUSION: C.longa mediated AgNPs showed potent antibiofilm activity.
METHODS: Characterizations of these biogenic nanoparticles were done by UV-Vis spectroscopy, TEM, EDX and nanoparticles tracking analyzer. Antibiofilm activity of AgNPs against S. aureus and S. pneumoniae was carried out by 96 well plate method. Further the combined effect of AgNPs with the antibiotic was studied against S. aureus and S. pneumoniae.
RESULTS: UV-spectroscopic analysis showed a surface plasmon resonance peak at 415nm. Shape of AgNPs is spherical with average size of 20-40 nm while the elemental silver was confirmed by EDX analysis. These biosynthesized AgNPs have anti-biofilm activity against S. aureus and S. pneumoniae. Furthermore, the combined effect of AgNPs with antibiotic, showed enhanced anti-biofilm activity against both the strains under study.
CONCLUSION: C.longa mediated AgNPs showed potent antibiofilm activity.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app